clavulanic acid has been researched along with Shock, Septic in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abruzzi, J; Kopczynski, A; Montes, THM; Nedel, WL; Portela, LV; Rodolphi, MS; Strogulski, NR | 1 |
| Antoun, S; Chachaty, E; Farhat, H; Nitenberg, G; Zahar, JR | 1 |
| Grossenbacher, R; Pennekamp, A; Tschirky, P | 1 |
1 trial(s) available for clavulanic acid and Shock, Septic
| Article | Year |
|---|---|
[Significance of Staphylococcus aureus in nose operations. Risk of toxic shock syndrome?].
Topics: Adolescent; Adult; Aged; Amoxicillin; Antibiotic Prophylaxis; Clavulanic Acid; Clavulanic Acids; Colony Count, Microbial; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Nasal Septum; Postoperative Complications; Prospective Studies; Rhinoplasty; Risk Factors; Shock, Septic; Staphylococcal Infections; Staphylococcus aureus; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
2 other study(ies) available for clavulanic acid and Shock, Septic
| Article | Year |
|---|---|
Antibiotic therapy does not alter mitochondrial bioenergetics in lymphocytes of patients with septic shock - A prospective cohort study.
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; beta-Lactams; Clavulanic Acid; Energy Metabolism; Humans; Lymphocytes; Meropenem; Mitochondria; Piperacillin, Tazobactam Drug Combination; Polymyxins; Prospective Studies; Shock, Septic; Vancomycin | 2022 |
[Two cases of Bacillus infection and immunodepression].
Topics: Amoxicillin; Anti-Bacterial Agents; Bacillus; Bacterial Infections; Ceftriaxone; Ciprofloxacin; Clavulanic Acid; Drug Therapy, Combination; Humans; Immunosuppression Therapy; Male; Middle Aged; Sepsis; Shock, Septic; Treatment Outcome | 2008 |